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Abstract 
Cervical cancer is the second most common malignancy that affects women worldwide 
(WHO, 2011). Adherence to cervical cancer screening practice guidelines and use of high-
quality screening practices by primary care providers (PCPs) can reduce associated rates of 
morbidity and mortality. With recent changes in practice guidelines stemming from evolving 
scientific evidence suggesting more frequent screening for cervical cancer leads to 
overtreatment, providers have not fully adopted newer, less frequent testing when indicated for 
otherwise healthy women. This research translation project involved the assessment of adherence 
to cervical cancer screening guidelines of 9 primary care providers (7 physicians and 2 nurse 
practitioners) employed at an urban outpatient internal medicine practice specializing in 
women’s care. The 9 providers completed a pre-test of three clinical vignettes to assess baseline 
knowledge of current guidelines. Post-testing followed an educational intervention on the 
guidelines, resulting in 100% accuracy for all 9 providers. Participants identified patient 
understanding of newer guidelines as a barrier to lesser interval screening. Supplying providers 
with patient education resources creates the opportunity for patient-provider collaboration while 
enhancing patient-centered care. 
 
Keywords: cervical cancer, cervical cancer screening, clinical practice guidelines, 
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Improving Provider Adherence to Recommended Cervical Cytology Screening Guidelines 
Problem Identification 
Cervical Cancer Screening Guidelines: Problem or Panacea? 
Cervical cancer is the second most common malignancy that affects women worldwide 
(WHO, 2011). The National Cancer Institute (NCI) (2012) defines cervical cancer as malignancy 
arising from the tissues of the cervix, which is typically slow growing and asymptomatic in 
nature. This year alone, over 12,000 women in the United States will be diagnosed with invasive 
cervical cancer, with the majority being under the age of 55 (NCI, 2012). While cervical cancer 
was previously listed as one of the most common causes of cancer-related death of women in the 
United States before screening was instituted, it no longer reaches the top 10 (Saslow et al., 
2012). When cervical cancer does occur, the majority of the time it is amongst women who have 
never been screened, or who have not been screened within the previous 5 years (Moyer, 2012; 
Saslow et al., 2012). The Papanicolaou (Pap) smear screening test for cervical cancer was 
introduced in the United States in 1941, and led to the first systematic effort to detect early 
cancer (Sirovich, Feldman, & Goodman, 2011). Since its introduction, Pap testing has been 
associated with a sustained reduction in cervical cancer incidence and mortality over many years.  
The dramatic decline of cervical cancer over recent years is attributed to increased use of 
cervical cancer screening technologies, including the Pap smear as well as human papillomavirus 
(HPV) DNA tests. Thanks to such screening, the cervical cancer death rate in women declined 
by almost 70% between 1955 and 1992 (American Cancer Society [ACS], 2012) and now ranks 
14th among cancer-related deaths in women. Secondary prevention through a screening regimen 
of cervical cytology with or without concomitant HPV DNA testing remains the best approach to 
protecting women from cervical cancer (American College of Obstetricians and Gynecologists, 
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[ACOG], 2010; Moyer, 2012; Saslow et al., 2012). Given these contemporary cervical cancer 
screening and diagnostic tools, as well as clinical practice guidelines for early detection, cervical 
cancer has become one of the most preventable forms of cancers affecting women (Sirovich, 
Feldman, & Goodman, 2011). Successful adherence to cervical cancer clinical practice 
guidelines and usage of appropriate high-quality screening and diagnostic tests by primary care 
providers (PCPs) can reduce rates of morbidity and mortality linked to cervical cancer.  
Statement of Problem 
When introduced too early or too frequently in a woman’s life, increased and unnecessary 
cervical cancer diagnostic screening procedures, including the Pap and HPV tests, can be 
detrimental to her cervical and reproductive health, causing risk for cervical incompetence and 
miscarriage, as well as psychological stress from invasive medical procedures and excisional 
treatments. A critical review of evidence investigating the problem of increased Pap and HPV 
diagnostic testing leading to potential development of incompetent cervices in women ages 15-
65 secondary to overuse of cervical cytology screening procedures as evidenced by the lack of 
provider understanding and compliance with current clinical guidelines is essential to better 
understand factors regarding why primary care providers do not consistently follow current 
screening recommendations when assessing women for cervical abnormalities at the cellular 
level. 
In recent years, clinical practice guidelines and recommendations have evolved based on 
scientific evidence that suggests more frequent testing for cervical cancer leads to overtreatment 
(ACOG, 2010; Moyer, 2012; Saslow et al., 2012). However, providers have not fully adopted 
newer, less frequent testing when indicated for otherwise healthy women. There is a crucial need 
to reaffirm these standards of care already employed by providers in everyday practice, which 
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have been shown to improve patient outcomes. Knowledge of and adherence to cervical cancer 
screening guidelines by primary care providers will help determine how best to disseminate and 
educate practitioners regarding its application. In an effort to better understand potential discord 
between clinical policy and current practice, the implementation of a research translation project 
may aid in further closing the gap between evidence regarding cervical cancer screening 
recommendations and current practice by primary care providers. Such a project may also 
provide meaningful evidence regarding the identification of specific changes that must be 
considered in order to increase adherence to recommended screening methods.  
Evidence of Problem 
Cervical cytology screening guidelines are created and frequently modified in order to 
help healthcare professionals appropriately screen women at risk. Current literature indicates that 
many primary care providers are not following guidelines on recommended screening intervals 
for cervical cancer with regards to the traditional Pap testing and DNA testing for HPV (Saraiya 
et al., 2010). As substantiated by much research, significant variation in cervical cancer 
screening among primary care providers has been noted (Holland-Barkis et al., 2006). The 
evidence based practice guidelines for cervical cancer screening are recommendations to all 
primary care providers employed in various settings and can aid in reducing unnecessary 
screening while improving screening for women at risk. Understanding the discord between 
clinical recommendations, policy, and practice can result in unnecessary testing costs and burden 
to women.  
A Critical Review of the Literature 
In preparation for the planning of this research translation project, a comprehensive 
evaluation of the literature for current cervical cytology screening recommendations and practice 
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guidelines, as well as problems with provider lack of understanding of and adherence to such 
guidelines, was performed utilizing the following databases: PubMed of the National Library of 
Medicine and the Cumulative Index of Nursing and Allied Health Literature (CINAHL). The 
following Medical Subject Headings (MeSH) terms were used to build a PubMed database 
search: cervical cancer, cervical neoplasm, human papillomavirus, Papanicolaou smear, and 
vaginal smear. Search terms for both databases included cancer, cervical cancer screening, 
cervical cancer treatment, Papanicolaou test, primary care, screening intervals, Pap testing, HPV 
screening, provider adherence, and guideline adoption. Inclusion criteria included full-text 
articles, English language only, cervical cancer screening in primary care setting, and women 
only (implied as inclusion criteria). Exclusion criteria included any studies focusing on guideline 
adherence for women requiring abnormal cervical cytology follow-up for high-grade 
precancerous cervical lesion or cervical cancer, as the focus of the review of literature was to be 
on preventive screening methods only. The literature provided valuable information pertaining to 
cervical cancer screening recommendations, risks associated with screening, the use of research 
evidence in practice, and barriers to guideline adoption. 
An organized review of current peer-reviewed literature and evidence suggests that many 
primary care providers (PCPs) are not following clinical practice guidelines on recommended 
screening intervals for cervical cancer with regards to the traditional Pap and HPV testing 
(Holland-Barkis et al., 2006; Meissner et al., 2010; Roland et al., 2011; Saraiya et al., 2010). As 
sustained by much of this research, significant variation in cervical cancer screening among 
PCPs has also been noted, and recent investigations purport that providers may not be embracing 
recommendations for cervical cytology screening, as many continually screen at inappropriate 
intervals (Holland-Barkis et al., 2006; Meissner et al., 2010).  
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National Cervical Cancer Screening Guidelines 
Differences may lead to screening practice problems. 
There is supportive evidence that updates and recommendations to clinical practice 
guidelines for cervical cancer screening are relevant resources for clinicians, policy makers, and 
researchers alike with both interests and directives to promote the overall quality of cancer 
screening (Brouwers et al., 2011). Cervical cytology screening guidelines are created and 
frequently modified in order to aid PCPs in the appropriate screening of women at risk (Holland-
Barkis et al., 2006). Standards of practice by all providers to women must be consistent so that 
no unnecessary procedures or harm befalls women receiving cervical cancer screening (ACOG, 
2009).  
Cervical cancer screening guidelines in the U.S. are issued by three highly regarded 
organizations: USPSTF, ACS, and ACOG. Guidelines issued by these groups since 2002 are 
specific with respect to starting age, stopping age, screening frequency, and groups for whom the 
standard recommendations do not apply. While guidelines are not identical across all 
professional organizations with published cervical cancer screening guidelines, ACOG, ACS, 
and USPSTF have developed guidelines for providers who care for women of all ages and all 
allow for intervals of cervical cancer screening at least 2 to 3 years after age 30 if the female has 
had 3 consecutive normal Pap tests (ACOG, 2009; Moyer, 2012; Saslow et al., 2012; Schwaiger, 
2012). These guidelines are based on clinical trials presenting minimal differences in the 
cumulative reduction of cervical cancer in comparisons of one-, two- and three-year Pap test 
intervals and an understanding of the transient nature of most HPV infections (MacLaughlin et 
al., 2011).  
As there is some overlap among the aforementioned three major guidelines, subtle 
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differences have led to confusion regarding screening practices to be employed by clinicians 
(Schwaiger, 2012). A U.S. survey of clinician’s responses to screening vignettes, however, 
indicate that fewer than 25 percent would recommend screening consistent with the care agreed 
upon by all the guidelines, and choices representing overuse were most frequent (Yabroff et al., 
2009). Much of the current literature reviewed surrounding provider understanding and use of 
cervical cancer guidelines is supportive of the fact that providers may not be adopting these 
recommendations for screening and are continuing to screen annually for cervical cancer, which 
may be contributing to over-screening and over-treatment of women who are not at high risk for 
developing cervical dysplasias (Holland-Barkis et al., 2006; Moscicki & Cox, 2010; Roland et 
al., 2011; Saraiya et al., 2011; Schwaiger, 2012). 
Potential harms of screening for cervical cancer include, but are not limited to, anxiety of 
an abnormal test result, the risk of increased testing and costly invasive diagnostic procedures 
such as bleeding or infection, and risks of treatment including adverse pregnancy outcomes 
(ACOG, 2009; ACOG, 2010; MacLaughlin et al., 2011; Moyer, 2012; Saslow et al., 2012). To 
minimize such risks for unfavorable outcomes and potential hazard, recent revisions to screening 
guidelines have sought a balance to maximize the benefits of screening while minimizing the 
potential harms. Both the USPSTF and the ACS in combination with the American Society for 
Colposcopy and Cervical Pathology (ASCCP) and the American Society for Clinical Pathology 
(ASCP) released updated guidelines in early 2012 recommending screening for cervical cancer 
in women age 21 to 65 years with cytology (Pap smear) every 3 years or, for women age 30 to 
65 years who want to lengthen the screening interval, screening with a combination of cytology 
and HPV testing every 5 years (Moyer, 2012; Saslow et al., 2012). These recommendations are 
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made without regards to sexual history of the female being screened (Moyer, 2012; Saslow et al., 
2012).  
According to ACOG, whose most recent cervical screening clinical practice guidelines 
were last revised in 2009, the endorsement to begin cervical cytology screening at age 21, 
regardless of age of onset of sexual intercourse, is based in part on the limited incidence of 
cancer among young women, and as well as the risk of possible adverse effects or experiences 
endured during the course of follow-up for these young women with abnormal findings from 
cytology screening (ACOG, 2009). Previously, ACOG’s recommendations had proposed that 
providers caring for women in the primary care setting should begin cervical cancer screening 
three years after first sexual intercourse or by age 21, whichever occurred first. In order to avoid 
economic, emotional, and future implications of unnecessary treatment of adolescents, ACOG’s 
guideline suggests that there be transition from baseline cervical cancer screening to age 21, 
unless otherwise implicated by potential risk factors (ACOG, 2009; ACOG, 2010; Moscicki & 
Cox, 2010).  Like ACOG’s latest screening recommendations, the USPSTF and ACS also 
recommend against screening for cervical cancer in women younger than age 21 years. USPSTF, 
ACS, and ACOG all base their endorsements and recommendations on high quality, consistent 
scientific evidence (Level A recommendations) (ACOG, 2009; Moyer, 2012; Sirovich, Feldman, 
& Goodman, 2011; Saslow et al., 2012; Schwaiger, 2012).  
There is considerable supportive evidence that updates and recommendations to clinical 
practice guidelines for cervical cancer screening are relevant resources for clinicians, policy 
makers, and researchers alike with both interests and directives to promote the overall quality of 
cancer screening (Brouwers et al., 2011). Cervical cytology screening guidelines are created and 
frequently modified in order to aid PCPs in the appropriate screening of women at risk (Holland-
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Barkis et al., 2006). Standards of practice by all providers to women must be consistent so that 
no unnecessary harm befalls women receiving cervical cancer screening (ACOG, 2009).  
Use of the Research Evidence in Practice 
Data suggestive of poor adherence to the ACOG, USPSTF, and other cervical screening 
guidelines are common (Holland-Barkis et al., 2006; Moscicki & Cox, 2010; Roland et al., 2011; 
Saraiya et al., 2011). As supported by Roland et al. (2011), who assessed HPV test practices and 
Pap test screening interval practices of U.S. PCPs, there is a clear need to document the 
implementation of screening methods and guideline adherence by providers, given the ever 
changing advancements in the health care fields, increasing new technologies, and emerging 
practice guidelines. The USPSTF has long recommended extending cervical cytology screening 
(by means of Pap testing) intervals up to every three years (ACOG, 2009; Whitlock et al., 2011). 
A systematic review by Whitlock et al. (2011) for the USPSTF revealed evidence 
supporting the use of liquid-based vs. conventional cytology screening of cervical cancer. 
Whitlock et al. (2011) suggest there is need for more complete evidence before enhanced HPV 
testing as a means of primary screening is widely adopted, while some key details remain 
ambiguous, including how early detection may be improved, whether such an approach would 
have a positive effect on detection of invasive cervical cancer, and if potential burden and harm 
suffered would ensue. Such findings highlight the significance of the need for PCPs to 
understand appropriate methods and intervals of cervical cancer screening. 
In 2011, 1,212 PCPs were surveyed about their cervical screening practices. The data 
revealed that 950 of the total PCPs surveyed performed Pap tests and recommended the HPV test 
for patients (Saraiya et al., 2011). Participants in the study reported their screening 
recommendations in response to clinical vignettes. Other investigations have studied the 
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adoption of cervical cancer screening recommendations by PCPs through cross sectional analysis 
with multi-stage probability samples, where the main outcome measure included self-reported 
data using clinical vignettes (Holland-Barkis et al., 2006; Meissner et al., 2010; Roland et al., 
2011). Although these studies used large, national population-based samples, yielding high 
response rates, limitations of such investigation may include response bias, and the fact that 
survey response answers may not reflect other factors that may influence practice (Holland-
Barkis et al., 2006; Saraiya et al., 2011).  
The use of clinical vignettes was a notable trend when reviewing the evidence on PCPs’ 
practice of cervical cancer screening (Holland-Barkis et al., 2006; Meissner et al., 2010; Roland 
et al., 2011; Saraiya et al., 2011) and is regarded as a reliable tool for PCPs’ self-report of 
practice (Saraiya et al., 2011). Clinical vignettes are used to describe clinical conditions to 
illustrate unique and important teaching points. As suggested by Veloski et al. (2005), clinical 
vignettes provide insight into clinical practice, education, or research in both outpatient and 
hospital settings. Veloski et al. (2005) also propose that open-ended clinical vignettes are 
evidenced based, valid, and cost-effective tools to use when evaluating primary care providers’ 
quality of care and practice variation in an outpatient setting, especially when compared to 
standardized patients and chart abstraction. The clinical vignette, when used in conjunction with 
additional education strategies, is a potentially efficacious solution to improve the lack of 
provider adherence to and understanding of newer cervical cancer screening guidelines by 
reaffirming and reeducating providers’ knowledge of such updated practice recommendations. 
Barriers to Guideline Adoption 
This critical review of evidence surrounding current cervical cancer screening practices 
has largely shown that while the clinical practice guidelines for cervical cancer screening are 
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well written, revised, and supported by research, they are often not being used correctly by 
providers. There also exists some confusion surrounding newer guidelines. Numerous barriers, 
along with possible solutions to such barriers, which may potentially influence the adoption of 
appropriate cervical cancer screening practices, are proposed in current literature, but warrant 
further investigation and study (Holland-Barkis et al., 2006; Meissner et al., 2010; Moscicki & 
Cox, 2010; MacLaughlin et al., 2011, Saraiya et al., 2011).  
Varied adherence to published guidelines may be due to limited awareness, familiarity, 
agreement, self-efficacy, or outcome expectancy (Holland-Barkis et al., 2006), as well as other 
factors associated with less frequent screening by PCPs, such as the USPSTF possessing great 
influence over clinical practice (Meissner et al., 2010). Moscicki & Cox (2010) offer that other 
possible confines may include government legislation, loss of pretext for health screening, along 
with time constraints present in primary care. A wide variation of adherence to guidelines may 
also be due to significant intra-specialty differences regarding adherence to the providers’ own 
specialty’s guidelines (Holland-Barkis et al., 2006; Meissner et al., 2010; Saraiya et al., 2011). 
MacLaughlin et al. (2011) identified women’s belief about cervical cancer testing frequency as 
the strongest predictor of attitude toward less frequent screening. They suggest that future 
research should explore why some patients continue to expect annual testing and identify 
interventions to help providers elicit and reform patients’ expectations about cervical cancer 
screening. 
Review and analysis of high-quality evidence is crucial to evidence based practice, and 
the identification of solutions to defined problems within evidence-based practice is just as 
critical. Brouwers et al. (2011) systematically retrieved best evidence available to find which 
interventions have been shown to increase the uptake of cervical cancer screening. After a 
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systematic review of 66 studies, investigators concluded that reduced structural barriers, and 
supplying PCPs with both evaluation and feedback were suggested interventions to improve 
screening practices (Brouwers et al., 2011). Research shows that these interventions to increase 
adoption of cervical cancer screening will need to take place at multiple stages in order to 
increase adherence by PCPs, such as the utilization of informed decision-making interventions, 
which may reduce unwarranted testing, as well as the suspension of insurance coverage for 
annual Pap tests when they are not appropriately indicated (Briss et al., 2004; Meissner et al., 
2010). Regardless, policy makers should be cognizant of implementation costs associated with 
newer technology, training, and reimbursement in determining the best approaches for promoting 
practices that are supported by the latest scientific evidence as included in practice guidelines 
(Meissner et al., 2010). 
Theoretical Foundation: Knowledge-To-Action Model 
 The knowledge-to-action (KTA) cycle, or model, is a comprehensive framework that 
incorporates the full cycle of knowledge translation from knowledge creation through 
implementation and impact (Graham et al., 2006). Integration of knowledge creation and 
knowledge application represents the theoretical foundation to support the implementation of a 
program to increase adoption of cervical cancer screening by primary care providers. Graham et 
al. (2006) proposed the KTA conceptual framework (Figure 1) as a valuable tool for facilitating 
the use of evidence based knowledge to identify gaps from knowledge to practice (White & 
Dudley-Brown, 2012). 
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Figure 1. The Knowledge-to-Action Cycle.
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the need to develop and apply best evidence for clinical practice, particularly those related to 
uptake and integration of appropriate cervical cytology screening methods and intervals. This is 
enhanced when all parts of the process consider the evidence and means to facilitate its 
implementation in practice, and when collaboration occurs among researcher, clinician, and 
when possible, patient. 
The KTA model provided a theoretical basis for identifying methods to improve provider 
adherence to cervical cytology screening guidelines through assessing barriers to knowledge 
utility, as well as through selecting, tailoring, and implementing educational interventions. 
Clinical vignettes were selected and used as a means to assess and re-assess provider 
understanding of current cervical cancer screening guidelines with the implementation of a 
programmatic educational intervention (pre/post-test design with review of educational handout 
on current practice guidelines). Use of the KTA cycle and framework is directed towards the 
outer action, or application, cycle.  
Organizational Analysis 
Group Description 
The clinical practice setting selected for the implementation of this research translation 
project was chosen given ease of access, locale, overall availability, and potential benefits for 
providers in practice, which in turn also benefits the adult female patient as the health care 
consumer. The project was implemented at in an outpatient, internal medicine primary care 
setting specializing in women’s health care, where providers offer comprehensive health care 
and routine gynecology services to young adult, middle-aged, older-aged, and elderly women 
living in the Greater Boston, Massachusetts area, receiving preventive health care, including 
cervical cytology screening (i.e., Pap smears, HPV screening).  
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The chosen practice organization is affiliated with Massachusetts General Hospital, a 
nationally ranked primary teaching hospital of Harvard Medical School and a biomedical 
research facility located in Boston, Massachusetts. The practice is located in a ten-floor 
outpatient care facility, one of the largest and most comprehensive outpatient buildings in New 
England. The specific women’s health practice serves a diverse population of female clients from 
age 18 throughout older adulthood. Demographic characteristics of the female population served 
by providers in this specific practice setting vary among age, race, ethnicity, and socioeconomic 
background, but includes clients from Boston (inner city), and many of its suburban regions, 
including those located on both the Northern and Southern shores of Massachusetts.  
The providers serving this select population of women include 15 board-certified, 
licensed physicians (MDs) and 2 nurse practitioners (masters prepared NPs) with specialty 
training and credentialing in family practice, general medicine, internal medicine, and women’s 
health care. The sample attained for this project included all licensed primary care providers 
(MDs and NPs) accountable to current cervical cancer screening guidelines (i.e., those published 
by ACOG and USPSTF), who were employed at the clinic described above at the time of project 
implementation, inclusively. Exclusion criteria included staff not licensed or certified to perform 
cervical cancer screening under their professional scope of practice (i.e. office or nursing staff, 
medical assistants). The sample of participants was a convenience (nonrandom) sample of 9 
primary care providers (7 MDs and 2 NPs) out of the practice’s 17 employed providers. This 
sample type was chosen given the nature of the project’s scope and accessibility to providers. 
As was noted during the preliminary stages of this project’s development during 
prerequisite studies of the DNP(c), it was a shared belief of many practice providers that current 
cervical cancer screening guidelines for women are ever-changing and many felt it difficult to 
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stay abreast of new information and modifications of such guidelines. Most providers 
acknowledged that they were familiar with the current guidelines but frequently needed to refer 
back to the guidelines to be sure they were staying current with screening recommendations. 
Prior to project implementation, providers at the practice agreed that this project could help to 
improve performance and positively influence office visits with female clients requiring 
appropriate cervical cancer screening, while remaining relatively cost and time neutral for the 
entire practice. It was the hope of the providers, this DNP(c), and the practice manager that the 
improved screening practices and performance of providers would become part of the overall 
provision of care and comprehensive services delivered to women in applicable age groups at 
this primary care internal medicine practice.   
Engaging Key Stakeholders 
The purpose of this performance improvement project was to evaluate the knowledge and 
awareness of primary care cervical cytology screening guidelines among a primary care practice 
that employs multi-disciplinary providers, including 15 physicians as well as 2 nurse 
practitioners. Effectively engaging these individuals as key stakeholders was vital for the success 
of this project, as well as the completion of a needs assessment to determine the presence of gaps 
in practice relative to this project’s defined population and the specified health problem (see Key 
Stakeholders agreement letter in Appendix A). The key stakeholders were all of the providers 
employed at the practice, as well as the female patients who receive cervical cancer screening 
pursuant to current clinical practice guidelines. The 17 providers’ participation in this project 
was a core measure in the success or failure of this research translation project that emphasizes 
performance improvement. A total of 9 out the 17 employed providers agreed to be a part of this 
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project and those who participated understood the importance of the project outcomes as they 
relate to potential performance improvements.  
Resources, Facilitators, and Barriers 
Given that the type and amount of resources required for the implementation of a needs-
based health program may vary with the interventions used, the expertise of the personnel and 
facilitators, characteristics of the targeted audience, and the acquisition and management of 
resources all affect the success of a program (Issel, 2004). Organizational planning for this 
performance improvement project included: informational resources (computer hardware and 
software), monetary resources (budget as provided by this DNP(c)), physical resources (project 
materials, facilities, and equipment), managerial resources (project facilitator), and time 
resources (planned timeline and provider availability). Such organizational plan objectives aided 
in directing and determining critical aspects and components of implementing this research 
translation project. The project facilitator was the author of this research translation project, a 
DNP candidate enrolled at the University of Massachusetts Amherst, School of Nursing.  
During planning phases for this research translation project, verbal and written 
agreements were made among the practice manager, several practice providers (including the 
DNP(c)’s clinical preceptor/mentor), and the DNP(c) to use practice resources available, 
including the practice’s conference room for full access to providers at a weekly meeting 
typically conducted during regular business hours. However, given unforeseen circumstances 
involving changes to provider scheduling and availability of practice’s conference room, the 
implementation strategy of the project was modified from using a group method to approaching 
each provider individually regarding their willingness to participate in the project. Finances were 
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limited, but were relatively low for the DNP(c) who served as the main source of finances for 
this project’s implementation. Further cost analysis is outlined later in this report. 
Potential barriers and constraints to the project implementation included: time required to 
reeducate the providers on recent changes and updates to cervical cancer screening guidelines, 
time constraints given providers busy patient schedules, varying provider schedules, provider 
resistance to change (including differences in culture, beliefs, and perceived ability to apply the 
screening recommendations, especially among patients who may also be resistant to receiving 
cervical cancer screening at lesser intervals). While it was an anticipated barrier on the part of 
the DNP(c) in project planning phases, providers’ lack of awareness or knowledge of changes to 
current cervical cancer screening guidelines was not a barrier to project implementation. The 
current recommendations and guidelines for cervical cancer screening in women ages 21-64 was 
summarized in chart form and distributed to all providers, so that they could easily reference 
screening recommendations despite potentially demanding patient schedules (Appendix B). 
Although the pre-post test design planned for this implementation project offered several 
advantages (i.e., ease of administration, efficient, minimally disruptive to providers’ clinical 
responsibilities), its limitations should also be acknowledged. Such limitations or barriers to 
implementation involving standard pre-post design is that this project design afforded only two 
data points per provider, and also lacked the use of a control group. These limitations were 
therefore considered within the context of this project’s outcomes and overall utility. 
Protocol and Plan 
A program evaluation design was chosen for this research translation project. A total 17 
primary care providers were approached about participation in the project, and 9 providers (7 
MDs and 2 NPs) from the women’s health outpatient internal medicine practice established in 
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Boston, Massachusetts were successfully recruited and agreed to participate in the project. All of 
the providers were certified and trained in the comprehensive health care of the adult female 
client. Clinical vignette-based surveys (included below in Table 1) were used as a part of a 
programmatic educational intervention in order to examine provider report of recommendations 
for next interval cervical cancer screening of a hypothetical 35 year-old female patient receiving 
care in the primary care setting. For the purpose of this project, a clinical vignette-based pre-test 
survey of provider knowledge was administered (Table 1), followed by a 10 to 15 minute 
discussion between the participant and the DNP(c) regarding the review of a printed educational 
handout referencing the current best practice of cervical cytology screening according to 
nationally recommended clinical practice guidelines (Appendix B). This review and discussion 
was then followed by a subsequent post-test (Appendix C).  
Table 1. Clinical Vignette-Based Survey Questions 
Clinical Vignette 1 
A 35 year-old female patient presents to your primary care office for a comprehensive physical 
exam. Her 3 most recent annual Pap test results have been normal and she denies any new 
sexual partners during the past 5 years. What cervical cytology screening, if any, would you 
recommend at this visit? 
Clinical Vignette 2 
A 35 year-old female patient presents to your primary care office for a comprehensive physical 
exam. Within the past 5 years, she has had 1 normal Pap test result and denies any new sexual 
partners. What cervical cytology screening, if any, would you recommend at this visit? 
Clinical Vignette 3 
A 35 year-old female patient presents to your primary care office for a comprehensive physical 
exam. She has a negative HPV test result and a normal Pap test result from this year. What 
cervical cytology screening, if any, would you recommend at this visit? 
 
The educational handout reviewed with project participants is a duplicate of the 2012 
USPSTF clinical summary of the most current cervical cancer screening recommendations. It is 
important to note that revision to the handout was not necessary from the planning stages of the 
research translation project to project actualization, as current cervical cancer screening 
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guidelines were not updated during the elapsed time between project design and implementation. 
It should also be noted that as this performance improvement project launched, appropriate and 
applicable adjustments to its plan were made where and when appropriate, dependent upon the 
manner in which the research translation project unfolded. 
Project Implementation 
Methods 
A total of 9 primary care providers were recruited for this performance improvement 
project, and upon their individual agreement of participation in the project, all were assessed, 
educated, and then re-assessed on their knowledge and awareness of current cervical cancer 
screening guidelines used within primary care. Participation was strictly voluntary and 
arrangements for formal meeting times were made between each participant and the DNP(c) 
prior to the project’s initiation. This was a modification from the initial project proposal, with the 
aim of engaging the most participants as possible via one-on-one meetings versus a singular one-
time group meeting within the practice setting. Agreements and planned commitments for one-
on-one meeting times with the DNP(c) and the participating provider were arranged at times so 
not to interfere with patient visits and other provider responsibilities. All providers were asked to 
consider participation on the project, and those who were agreeable were given the pre-test 
clinical vignette-based survey to complete independently within five to ten minutes, and were 
then asked to return the pre-test to the project investigator.  
The clinical vignette-based survey tool used during both pre- and post-testing was the 
sole data collection tool. Basic descriptive statistics were used to evaluate the results of the 
clinical vignette-based surveys completed during program implementation. The program 
intervention of providing clinician education by means of an educational tool occurred between 
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pre- and post-testing of this one group. This research project design focused on the pre-testing of 
a single group, followed by the exposure to an intervention (educational program), and 
culminated with post-testing following the intervention. The overall success of the project was 
determined by comparing pre-test and post-test data to determine if provider exposure to 
education pertaining to most current cervical cancer screening clinical practice guidelines 
impacted adherence to the guidelines in practice.  
Additionally, qualitative data regarding provider’s perceived understanding of and 
adherence to current guidelines, as well as barriers to successful implementation of 
recommended screening practices, was collected during one-on-one meetings between the 
DNP(c) and the project participants. This aided the DNP(c) in making logical inferences from 
project results, while also helping to identify obstacles to project sustainability. Content analysis 
including the generation of inferences from communication during one-on-one meetings with 
participants was also used to outline common factors essential to effective cervical cancer 
screening guideline use in primary care practice.  
Those who agreed to participate then received a brief educational review of current 
clinical practice guideline recommendations (approximately 10 to 15 minutes) pertaining to 
cervical cancer screening among women ages 21-64 within the primary care setting (Appendix 
B). Following the educational programmatic intervention, participants were then asked to 
complete the post-test (an identical clinical vignette-based survey, see Table 1) to assess for 
awareness of the clinical guidelines following the educational intervention. Participants had then 
successfully fulfilled the requirements of the first phase of this project’s initially planned 
implementation, and were then asked to consider and apply the education provided pertaining to 
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cervical cancer screening as they deliver comprehensive and preventive health care to their 
female clients ages 21-64.  
The initial proposed plan for this implementation project included a second phase where 
the original group of project participants would receive a repeat post-test approximately one 
month after initial evaluation using the same clinical vignette-based survey from the initial phase 
of the project. However, given the overwhelming correct response rate to pre- and post-test 
clinical vignette-based surveys by all participants, the project plan was modified to omit this 
additional phase. In order to efficiently manage the project’s data, the pre-test version of the tool 
was printed on a different colored paper (yellow) than the post-test version of the tool (lavender) 
to easily differentiate between the pre- and post-test and to ensure that the data remained 
distinctly separate. Data was subsequently entered into a Microsoft Excel spreadsheet for data 
management and analysis.  
Goals 
As defined by Issel (2004), goals are broad statements regarding the outcomes to be 
achieved with the implementation of a specific health program. The overall encompassing goals 
of this performance improvement project were to effectively inform and educate primary care 
providers at a women’s health outpatient internal medicine practice on the most current cervical 
cancer screening guidelines, and to provide further education and support which would equip the 
providers with quick reference and access to summary recommendations of the current cervical 
cytology screening guidelines in order to increase the direct application of these current practice 
recommendations. This DNP(c) as the principal investigator of this impact evaluation design 
project aimed to accomplish these goals by first assessing provider awareness and knowledge of 
cervical cytology screening recommendations, followed by providing the in-person educational 
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programmatic intervention aimed at increasing awareness to current guideline standards through 
the use of an educational handout, and then conclude with re-assessing provider knowledge via 
self-reported responses to correct methods of interval cervical cytology screening based on 
clinical vignette-based surveys (post-test analysis).  
Objectives 
Performance improvement programs require goals and expected outcomes that drive the 
project, including the evaluation of the impact of the project, as well as data collection and 
analysis. Quality effect objectives refer to the program participants and the benefits they will 
experience as a result of receiving the program interventions (Issel, 2004). Objectives are 
specific statements regarding the potential impact of a health program’s implementation, stated 
in measurable terms. Specifically, clearly stated effect objectives will guide the evaluation of a 
program by providing reference to a time frame, the program participants to be affected, a health 
outcome related to the program interventions, and a quantifiable target value for that health 
outcome (Issel, 2004). 
There were three objectives of this impact evaluation project. First, recruit an adequate 
sample of providers agreeable to participation in the performance improvement project who have 
a present need for and baseline understanding of cervical cancer screening recommendations in 
women ages 21-64. Second, educating and re-affirming current clinical guidelines pertaining to 
cervical cancer screening in primary care through an educational programmatic intervention 
would ultimately aid providers in more effectively managing screening practices of this given 
population of patient clientele while altogether minimizing harm related to over or under 
screening. The final objective was the successful application of cervical cancer screening 
guideline recommendations following the performance improvement project’s implementation, 
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which directly impacts clients in a positive manner in regards to their comprehensive and 
preventive health care outcomes. However, this final objective was modified after initial project 
implementation given the initial positive responses by participating providers on the first pre- 
and post-test. The impact of the education program intervention was not subsequently evaluated 
through post-testing using the clinical vignette-based survey one month after the program’s 
initial implementation, given that all participants’ response rate was mastery at baseline. 
Outcome Expectations 
The measurable outcome expectations for this project were as follows: of the available 
practice providers, 75% would be successfully recruited and agree to participate in this 
performance improvement project through completion (13 out of 17 providers); 60% of sampled 
providers who screen women ages 21-64 routinely for cervical cancer would demonstrate 
increased knowledge pertaining to current best practices of cervical cancer screening, and 
responses to clinical vignette-based surveys as well as one-on-one interviews would show that at 
least 60% of sampled providers would find the use of the educational programmatic intervention 
supplied during the program helpful in the direct care of their patients, essentially decreasing the 
chance for poor outcomes or potential adverse harms related to inappropriate cervical cancer 
screening practices. 
In order to document changes across pre- and post-test conditions, accuracy scores for 
each provider-completed clinical vignette-based survey were obtained. The same patient-focused 
vignettes were used as a pre- and post-test during the implementation of the program, though 
participants did not receive any feedback during the pre-testing phase until they completed a 
post-test. Expected outcome measurement helped to set parameters for impact analysis and 
included the evaluation of reported open-ended recommendations for the timing of screening 
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intervals for the hypothetical 35 year-old female patients using the three different vignettes. In 
each clinical vignette, screening was to be performed by a licensed and certified primary care 
provider.  
Budget: Cost and Benefit Analysis  
 Budgets are a means for planning and tools for communicating priorities need for a health 
program. By projecting dollar and time costs in advance of project implementation, the DNP(c) 
was able to assess fiscal feasibility of the planned impact evaluation project (Issel, 2004). The 
development of a budget with cost/benefit analysis in terms of costs in time and revenue to a 
practice setting, as well as potential benefits to clients and providers, helped to highlight the 
programmatic necessities warranted to be fiscally responsible and efficient. As the project 
investigator, the DNP(c) contributed all of the funds necessary to implement this project at all 
stages. The financial budget for the project was low, as the total cost came to $92.00, as outlined 
in Table 2. 
Table 2. Cost Itemization 
Item Cost 
Physical Materials 
1 ream of multi-colored printer paper  $10.00 
1- 18 pc pack of standard ballpoint pens  $5.00 
Copying/printing of project 
handouts/questionnaires 
$17.00 
Computer Information Systems 
Laptop equipped with Microsoft Excel software 
(not needed for purchasing for project)  
$1,000.00 [not included in total cost of project; 
owned by DNP(c)] 
Personnel 
DNP candidate as project investigator 
 
3 credits ($750 per credit)= $2, 250.00 
[not included in total cost given educational 
benefits of project incurred by DNP(c)] 
Transportation/Travel 
Travel/commuting expenses to/from practice 
setting (MBTA public transportation/parking) 
$20.00 round trip fare cost x 3 trips= $60.00 
Project Space for Program Implementation 
Meetings spaces (located within practice setting) No cost (available free of charge within practice 
setting, i.e. provider offices/exam rooms) 
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Total Cost/Expenses 
Total Estimated Cost 
Total Estimated Cost for Project (minus costs of 
services volunteered) 
 





$92.00 (final cost of project implementation) 
 
 
Actual costs, as funded by the student investigator, included physical materials (i.e., 
colored paper, pens, printing of educational handouts/photocopies- ~$32.00) and gas/commuting 
expenses (i.e., transportation to/from practice setting at scheduled times- ~$60.00). Student time 
in conjunction with planned course work hours were used to analyze and evaluate outcome data 
and disseminate results by the DNP(c), who absorbed the cost of designing the educational 
handouts, educating the providers through the planned programmatic intervention, implementing 
the project in its entirety, and analyzing the results.  
There was no expected loss of revenue through blocked-off patient office visits, as the 
program took place during pre-established one-on-one meeting times committed to by each 
participant and the DNP(c) outside of patient visit hours (i.e. lunch breaks). Thus, it was the 
belief of the DNP(c) that the cost in time was generally low, revenue generated by patient office 
visits remained unaffected, and providers and patients alike benefited from the expected outcome 
of enhanced provider knowledge of cervical cancer screening guidelines at the completion of this 
impact evaluation project. As the project participants, providers and patients at the designated 
practice setting benefited from the educational and performance improvement opportunities 
rooted within the project, which has a direct impact on the standard care of patients seen by MDs 
and NPs at the practice. Therefore, it was the belief of the DNP(c) that benefits largely 
outweighed any time potential costs or overhead donated by the practice setting and participating 
providers.  
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Protection of Human Subjects  
This project involved the utilization of a clinical vignette-based surveys as well as 
programmatic educational interventions to assess provider understanding of current cervical 
cancer screening guidelines and to help close this knowledge-to-practice gap relating to 
standards of care. The provider, rather than the patient, was the human subject. Given the 
program evaluation design of this project, as well as the reduced risks posed to its participating 
subjects, it was exempt from Institutional Review Board (IRB) requirements of both the 
practice’s organizational IRB protocols and the University of Massachusetts Amherst where the 
DNP(c) is enrolled.  
There were no identifiable or discernible risks to the project participants, nor was there a 
need to identify any participants’ identity (i.e., the study did not collect personal data that is 
identifiable other than pairing pre- and post-tests with a non-identifying numeric code to allow 
for participant pre-post comparisons). Confidentiality was maintained at all stages of the research 
translation project and providers completing the clinical vignette-based surveys were asked to 
not write their name on their completed surveys. The protection of data collected was maintained 
through storing data in a locked storage area within the DNP(c)’s personal home office. As it 
was not applicable to this project’s implementation, no actual patient data was reviewed or 
obtained from medical records; therefore there was no breech in policies surrounding the Health 
Insurance Portability and Accountability Act (HIPPA). 
Timeline of Project Actualization 
In order to stay on course for timely completion of this performance improvement research 
translation project, an initial timeline was developed by the DNP(c) in pre-planning stages as a 
representation of specific dates, time spans, and sequence of events in planning, initiating, 
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sustaining, and evaluating this health program. The projected timeline and actions to complete 
are outlined in Table 3. 
Table 3. Timeline of Actions 
Timeline Action 
September 2012 – November 
2012 
• Capstone project proposal formulated (beginning phases) 
• Materials prepared (i.e., vignettes, educational handout)—
both pre- and post-tests 
December 2012 – January 
2013 
• Identified the clinical setting 
• Verified exemption of IRB (at both practice site and 
University of Massachusetts Amherst) 
• Capstone project proposal accepted 
January 2013 • Contracted the clinical setting, described and disseminated 
project plans, while identifying key stakeholders within 
practice setting 
January 2013 – February 
2013 
• Met with clinic management, practice manager, and project 
mentor to provide in-depth review of project plans 
March 6, 2013 
March 7, 2013 





• Initiated impact program 
 Pre-testing 
 Educational intervention supplied to 
participating providers 
 Post-testing 
 Debriefing during one-on-one meetings 
with participating providers (journaling of 
qualitative results)  
 Data collection completed  
March 2013 – April 2013 • In depth data analysis following project implementation to 
assess provider knowledge and awareness of cervical 
cytology screening 
Late April 2013 – May 2013 • Written research translation project evaluation and 
interpretation of findings submitted to UMass Amherst 
faculty and MGH WHA providers. Completed written 
submission of Capstone Scholarly Project submitted for 
approval and degree completion; presented to professional 
audience on UMass Amherst campus. 
 
 
The complete timeline for the implementation of this project from start to finish was 
September 1, 2012 through May 2013. Benefits of the timeline included its utility as a 
communication tool for conveying responsibilities and deadlines, as well as keeping activities 
coordinated and within sequence and allowing for communication of accountability for assigned 
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actions to complete, while helping to estimate personnel and material costs (Issel, 2004). It also 
served as a guide and frame of reference for the DNP(c) in successfully completing all time-
sensitive requirements to be considered for eligibility and granting of the clinical practice 
doctorate in nursing. 
Results 
Data Collection 
A mixed method approach was used in the evaluation of this performance improvement 
project focusing on impact evaluation in order to permit parallel mixed analysis. This mixed 
method approach allowed for the concurrent analysis of both quantitative and qualitative data. 
When utilizing mixed methods in data analysis, investigators purposely integrate or combine the 
quantitative and qualitative data rather than separating them, with the intention being that such 
integration leads to maximizing the strengths of the quantitative and qualitative data and 
minimizes their weaknesses (Creswell, Klassen, Plano Clark, & Smith, 2011). A mixed methods 
approach to data analysis involves more than simply collecting qualitative data from interviews, 
or collecting multiple forms of qualitative evidence (i.e., observations and interviews) or 
multiple types of quantitative evidence (i.e., surveys responses); it involves the intentional 
collection of both quantitative and qualitative data and the combination of the strengths of each 
to incorporate into data analysis of a performance improvement project focused on examining 
standards of care (Creswell, Klassen, Plano Clark, & Smith, 2011). 
Quantitative Data: Descriptive Analysis 
Initial evaluation of results included analysis of the percentage impact of this program 
intervention based on the defined goals and outcomes. Three primary objectives of this impact 
evaluation design performance improvement project were evaluated: successful recruitment for 
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project participation; provider demonstration of increased knowledge of cervical cancer 
screening based on responses to clinical vignette
of finding the educational programmatic intervention supplied during the project useful in 
improving standards of care.  Of the 17 
chosen for the implementation of this project, 9 providers 
this project (53% participation). These results
DNP(c)’s projected outcome expectation of a 75% recruitment and participation rate for this 
research translation project.  
Figure 2. Pie graph representation depicts provider participation in research translation project.
Quantitative data analysis for this project consisted of calculating the percentage of 
correct answers from each pre- and post
cancer screening guidelines based on the educational intervention included in the project. 
Individual and group mean scores were calculated and compared both within and between 
conditions (i.e., pre- and post-testing). 
with participants, each sampled provider
Provider Participation
  
-based surveys; and participating provider report 
participating providers employed at the practice setting 
(n=9) were successfully recruited for 
, represented below in Figure 2, did not meet the 
-test in an effort to evaluate understanding of cervical 
Prior to the educational intervention’s implementation 
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clinical vignette-based survey, which included a total of 3 questions
screening intervals. Following the im
discussing and reviewing the educational handouts with 
interviewing of each participant by the project investigator
survey. While the outcome expectatio
results demonstrated 100% accuracy of participating providers (9 out of 9 providers) who 
routinely screen women ages 21-
best practices of cervical cancer screening
vignette-based survey. Figures 3 and 4
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Figure 4. Post-test scores show sustained knowledge of guidelines with educational intervention.
Group means of both pre-
intervention positively influenced 
cancer screening guideline recommendations. As can be visualize
no changes found in provider knowledge following the educational intervention, as the 
provider’s awareness of guidelines was mastery at baseline. However, 
providers (9 out of 9 providers) responding to the clinical vignette
interviews reported finding use of the educational programmatic intervention supplie
impact program helpful in the direct care of their patients, far exceeding the DNP(c)’s initial 
outcome expectation of 60%. Figure 5
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Figure 5. Percentage of participants reporting guideline education usefulness.
 
This pre-test/post-test design was used to evaluate the educational
intervention and the effectiveness of its review based on providers’ use of the recommendations
in practice. The impact evaluation design involved collecting data from program participants 
once at any time before and once at any time after they have received the program (Issel, 2004). 
A single group was pre-tested, subjected to an action, and
knowledge use and sustainment. The success of the project was ultimately determined by 
comparing pre-test and post-test 
understanding how exposing the participants to
the recommendations in the cervical cancer screening guidelines and reviewing with them the 
specifics within the guidelines, would impact the providers’ 
recommendations within clinical pr
Qualitative Data: Content Analysis
Qualitative data was collected through the use of 
collection of field notes. Qualitative data was 
as a qualitative method for planning and evaluation of an implementation project helps to 
Percentage of Participants Reporting 




 then tested again to monitor for 
data. Exclusively, the DNP candidate was interested in 
 up-to-date, most current education 
self-reported actions to use the 
actice.  
 
journaling, logical analysis, and 
evaluated using content analysis. Content analysis 
100%
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identify themes of survey questions addressed and their relevance to health program planning 
and evaluation, as thoughts and perspectives may be revealed in responses and dialogue from 
participants (Issel, 2004). Generation of inferences from communication during one-on-one 
meetings with participants aided in identifying shared beliefs of providers regarding the 
essentiality of effective cervical cancer screening guideline use within the primary care setting. 
Through logic analysis and review of field notes post project implementation and one-on-
one discussions with participants, it became apparent to the project investigator that while 
outcome results were consistent across all participants and conditions, there remains a strong 
possibility that outcomes were impacted by the specialty practice setting in which this project 
was implemented. Because all providers employed at the practice site who participated in the 
project hold some degree of specialty practice interest or certification in women’s health, it can 
be accurately assumed that these providers are well versed and educated on most current and 
updated evidence based research pertaining to the adult female population at their baseline.  
Responses related to participant perception of their level of understanding of cervical 
cancer guideline recommendations were similarly positive, but most providers admitted that they 
sometimes need to review the guidelines often to stay current. One provider stated, “we have 
excellent access to the updates because of our easy-to-use guidelines on the computer, and 
because we’re a women’s health practice”; with another provider noting, “it will really help to 
have the guidelines as a handout like you provided to quickly refer back to for my own use or if 
patients ask about them.” The providers also explained that having the printed guidelines readily 
available is very helpful not only as quick reference, but when dealing with increased workflow 
or patient assignments. From these statements and reflections, it can be inferred that providers 
benefit from having access to multiple guideline resources in their practice environment to 
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enhance their awareness of and adherence to current cervical cytology screening 
recommendations. 
When asked about the how participants were impacted on a regular basis by frequent 
practice guideline changes and updates, many expressed frustration and exasperation regarding 
the difficulty in keeping informed of guidelines and screening endorsements. Participants were 
quoted as saying, “it’s so hard to keep track of cervical cancer screening guidelines and 
changes”, as well as, “sometimes I confuse the old and new guidelines and mix them up if I don’t 
review the newest recommendations first.” Anecdotal evidence as referenced suggests that 
providers recognize and appreciate firsthand the challenges they face with remaining informed of 
screening recommendations endorsed by various expert organizations. To this end, another 
participant highlighted how, “it’s a tough period, the 6 months or so after a guideline changes, 
because everyone is doing a different thing with screening; that’s why having them on hand is so 
helpful as reference.”  
Participating providers were also instrumental in identifying possible sample biases based 
on the professional population that participated in this research translation project. While 
quantitative results and descriptive analyses are encouraging, the professional setting is in fact a 
specialty practice, and results could be skewed given that those participating are perhaps more 
likely than other general or family practitioners to be current on cervical cytology screening 
guidelines. As one participant noted, “this project would be important in a non-women’s health 
practice where women’s care isn’t the specialty focus.” This statement alone made by one 
participant is advantageous in helping to recognize ways in which to advance this project post 
implementation and also speaks to the potential for sustainability of the project.  
Additionally, providers highlighted an important themed barrier to implementing current 
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guideline screening practices: the individual patient. Most, if not all, participants independently 
recognized the individual patient as a potential barrier to adherence to newer cervical cancer 
screening practices, reporting that, “I have a really hard time getting women on board with these 
new changes calling for less frequent screening; they’re so used to annual screening.” Another 
added, “I find that patients have a mix of understanding, so it is important to get the guidelines 
out there to the public- it’s an important public service campaign to patients.” The necessity for a 
Pap smear or HPV test should not determine the need for health care or patients seeking out 
medical attention. With this, some project participants endorsed having a fear of losing patients 
in continued and annual comprehensive care that may not include cervical cancer prevention, 
citing that they “worry about losing patients who won’t come back for other aspects of routine 
health care.” Overall, qualitative results and data analysis were positive and significant to the 
evaluation of the project, and the logical inferences made helped to drive recommendations and 
implications for post-project continuation. 
Discussion 
This research translation project focused on identifying systems to improve provider 
adherence to and understanding of frequently revised cervical cancer screening guidelines and 
simultaneously examined how best to implement these guidelines into practice. Final 
interpretation and discussion of results was shared with all participants and practice providers, 
including those who did not participate in the project, following finalization of data analysis. 
Data gathered through the use of a clinical-vignette based survey tool supported the rationale that 
implementation of effective screening interventions and methods to improve provider adherence 
to recommendations are important for effectual, safe, and optimal screening practices. A detailed 
assessment of the self-report of interval cervical cancer screening practices by providers offers a 
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discrete facet of multiple larger processes that promote screening safety, reduce of harms 
associated with over screening and over treatment, improve provider/patient communication, and 
foster ongoing intensive education. All individual processes are means to closing the research-to-
practice gap between existing evidence and the current practice application of cervical cancer 
screening recommendations. 
Strengths 
Multiple strengths can be identified following evaluation of data collected and analysis of 
results. First, among the providers sampled in this women’s health specialty setting, there was no 
variation among providers, nurse practitioner or physician, in the recommendation of accurate 
interval cervical cancer screenings. Nurse practitioners and physicians were uniform and 
consistent in their awareness of cervical cancer screening clinical practice guidelines, supporting 
existing research that nurse practitioners are capable of managing comprehensive patient care 
requirements, including screening services, in the primary care setting (Robert Wood Johnson 
Foundation, 2012).  Research has found that nurse practitioners exceed physicians on meeting 
measures related to patient follow up; time spent in consultations; and provision of screening, 
assessment, and counseling services (Robert Wood Johnson Foundation, 2012). As evidenced by 
the consistency across all participating providers, the results of this research translation project 
suggest the same.  
An additional strength of the project was its impact evaluation design, which utilized 
open-ended survey questions versus multiple choice or true/false answer options. Recall of actual 
knowledge in pre- and post-testing was required by participants versus process of elimination or 
relying on environmental cues in the clinical setting that could serve as prompts evoking memory 
of recommended screening practices. Furthermore, through interviewing and qualitative analysis, 
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it was clear that providers were well-versed on current screening guidelines, and from their 
discourse and the subsequent interpretation of project findings, identifiable themes emerged. 
Providers identified patients as a clear barrier to implementing lesser interval screening changes 
in practice, given the inherent nature perhaps compelling some females to request annual 
screening, as was recommended per guideline recommendations in years past. The process of 
designing and implementing this scholarly research translation project shed light on how 
important it is for patients to be aware of cervical cancer screening updates just as much as 
providers, so that both parties can continually function as joint and integral parts of the patient’s 
collaborative and comprehensive women’s health care. This particular theme will help support 
future implications for extending translational research initiatives based on this topic. 
While the outcome expectation of 75% recruitment rate of project participants was not 
met, as was the aim of the project investigator, a success of this project was the respondent’s 
buy-in and complete follow through by all participants throughout the duration of the project 
(100% completion rate of 9 out of 9 providers). While only 53% of providers employed at the 
practice were available and agreeable to participate in the project, thus not meeting the initial 
outcome expectation, this is a promising outcome given that all participating providers 
committed to the project through completion, combined with the fact that busy provider schedule 
were previously identified in both the literature and by the DNP(c) as a possible structural 
barrier. A recruitment rate of 53%, with complete follow through by all sampled, is comparable 
to, if not better than, other quality improvement project fall-off and participation rates, especially 
when considering that this project did not offer participation incentives. 
Limitations 
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Though this research translation project focused on performance improvement of the 
defined standard of care in cervical cancer screening was successful, it is not without limitations. 
As mentioned previously, while both quantitative and qualitative results were encouraging, use 
of a convenience sample versus a randomized sample more representative of providers across 
other practice specialties may have reduced possible sample bias and skewed results, thus 
limiting generalizability. This project could be further improved in regards to design and 
sustainability if replicated in an alternate practice setting with the same target female population. 
Possible settings include, but are not limited to: family practice, general practice, urgent 
care/community health setting, or non-specialty internal medicine practice, all which would 
potentially employ providers (MDs, NPs, or PAs) trained, licensed, and certified to complete 
cervical cancer screening per practice recommendations. This may also require further 
adjustments and modifications of the impact evaluation design of the project, as the providers 
were not able to demonstrate changes in knowledge of guidelines and screening practices given 
that they exhibited mastery of the information at baseline in pre-testing. Retention, recall, and 
application of the education components would perhaps require longer monitoring and 
evaluation between pre- and post-testing to further its significance.  
Clinical vignette surveys based on hypothetical patient scenarios were used to elicit 
provider recommendations for interval screenings, and while sources like the clinical vignette 
has been deemed a valid tool for measuring quality of clinical practice (Veloski et al., 2005), 
these vignettes included broad, open-ended questions, which cannot adequately reflect the 
diversity or miscellany of women that may present in actual clinical practice. Also, the vignette 
survey tools used in this project cannot replicate observable or unobservable factors that could 
potentially impact clinical practice. Providers may overstate patient receipt of cervical cancer 
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screening and their perceptions of practices adherent to guidelines. Overstatements resultant of 
self-report may imply that adherence to screening practices are in actuality lower than reported in 
regards to this translational research project.  
Conclusions 
This research translation project can serve as groundwork for future investigation into 
helping expand standards of care as they relate to improving provider adherence to cervical 
cytology screening practices while emphasizing efforts to close the research-to-practice gaps 
associated with conceivable barriers to the uptake of such recommendations. This project also 
provided meaningful evidence and insight into feasible and specific changes that should be 
considered in effort to increase provider adoption of recommended cervical cancer screening 
methods. While there is concern that newer recommendations for triennial cervical cytology 
screenings, which may be lengthened further with HPV cotesting, resulting in less frequent 
patient visits for other preventive care since cervical cancer screening and annual care 
management which have been traditionally coupled, providers must reinforce the need for 
patients to return to practice settings for annual pelvic examinations. As one provider so 
perceptively noted in interviews, “Pap smears and pelvic exams are not synonymous; both play 
an important role in women’s health care.”  
One realistic next step in post-project continuation is the successful creation and 
dissemination of a patient education brochure on cervical cancer screening in an effort to help 
reduce the patient as a barrier to adherence to cervical cancer screening and to prevent 
unnecessary screening and over treatment. With the creation of such educational patient 
resources, providers will be able to accomplish the following based on their own use and 
understanding of current guidelines: participate in ongoing discourse with patients about new 
         CERVICAL CYTOLOGY SCREENING        46 
guidelines and screening recommendations, with the ultimate goal being to collaboratively 
improve patient outcomes; implement increased intervals for cervical cancer screening among 
eligible patients who are aware of guidelines and in agreement to planned screening; utilize HPV 
testing appropriately to enhance Pap testing and extend screening intervals; prevent unnecessary 
testing in patient populations that do not warrant cervical cancer screening; and successfully 
communicate guideline changes to patients in layperson terms to facilitate patient acceptance and 
practice adoption. Through such educational interventions planned for patient use, providers can 
play an integral role in promoting awareness, teaching, and improving educational strategies to 
facilitate changes and patient ways of thinking in regards to cervical cancer screening in light of 
recent screening guideline updates recommending longer interval screening. With the writing of 
this scholarly report, patient educational materials on current and comprehensive cervical cancer 
screening were in development, and are intended to be disseminated at the chosen practice site 
where this research translation project was implemented. 
After successfully completing requirements of this scholarly research translation project, 
it became evident to this DNP candidate that the sampled providers were not only advanced in 
their understanding of and adherence to current cervical cytology screening recommendations, 
they were well aware of significant barriers existent in current practice and culture which can 
potentially limit the utilization of ideal screening standards. There was a 100% positive approval 
rate endorsed by participants reporting their impression of clinical practice guidelines usefulness; 
while sampled providers were clearly well informed of guidelines, barriers to screening, and 
harms of over screening, these results should no go discounted or ignored, as it is evident, 
through the rigorous steps of implementing a research translation project, that education and 
awareness has a profound effect and impact on adherence of screening and prevention. Providers 
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in this group trusted that using references and resources, including those in the form of 
educational handouts, benefits their patients and improves the standard of care that they deliver.  
In future practice, this DNP candidate is confident that because of their engagement in 
such high level scholarly work and critical thinking, they will be successful in enhancing their 
objectivity and understanding of research translation, as a Capstone project provides the 
foundation for clinical investigation and sets the stage for a broader, sustained program of 
exploration in a chosen field of practice (Carlson and Hammersla, 2011). DNP graduates should 
be prepared to act as catalysts for change and assume primary roles for linking academic 
research and clinical practice to effect greater patient sensitive outcomes and improvements in 
standards of care. Sharing individual DNP discoveries such as the processes that unfolded as a 
result of this project will help shape future nursing practitioner roles in various practice settings, 
while collectively influencing health care outcomes of patient populations so that optimal 
standards of care are implicit and executed to the highest extent possible.  
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Appendix C: Answers to Clinical Vignette-Based Surveys 
 
Clinical Vignette 1 
 
A 35 year-old female patient presents to your primary care office for a comprehensive physical 
exam. Her 3 most recent annual Pap test results have been normal and she denies any new 
sexual partners during the past 5 years. What cervical cytology screening, if any, would you 
recommend at this visit? 
 
 
Answer: According to the most current guidelines by the American College of 
Obstetricians and Gynecologists (ACOG) and the USPSTF, appropriate responses for the 




Clinical Vignette 2 
 
A 35 year-old female patient presents to your primary care office for a comprehensive physical 
exam. Within the past 5 years, she has had 1 normal Pap test result and denies any new sexual 
partners. What cervical cytology screening, if any, would you recommend at this visit? 
 
 
Answer: An appropriate response for the second vignette included a Pap test every year 




Clinical Vignette 3 
 
A 35 year-old female patient presents to your primary care office for a comprehensive physical 
exam. She has a negative HPV test result and a normal Pap test result from this year. What 
cervical cytology screening, if any, would you recommend at this visit? 
 
Answer: Vignette 3 includes a separate response for the next HPV and Pap tests; the 
composite measure to be considered appropriate includes (1) the next Pap test in 3 years 




*Because the USPSTF has consistently recommended that screening intervals be at least every 3 
years, a response of every 3 years as a conservative but appropriate USPSTF response for 
vignettes 1 and 2 will be included as acceptable. 
 
Please note that the above answer information was not included on the final vignette tool 
provided to participants during this project’s implementation phase. 
